Melck D - Search Results

1

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

Di Marzo V, Melck D, Bisogno T, De Petrocellis L. Di Marzo V, et al. Among authors: melck d. Trends Neurosci. 1998 Dec;21(12):521-8. doi: 10.1016/s0166-2236(98)01283-1. Trends Neurosci. 1998. PMID: 9881850 Review.

2

Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.

De Petrocellis L, Bisogno T, Ligresti A, Bifulco M, Melck D, Di Marzo V. De Petrocellis L, et al. Among authors: melck d. Fundam Clin Pharmacol. 2002 Aug;16(4):297-302. doi: 10.1046/j.1472-8206.2002.00094.x. Fundam Clin Pharmacol. 2002. PMID: 12570018

3

Cannabimimetic eicosanoids in cancer and inflammation: an update.

Melck D, Bisogno T, De Petrocellis L, Beaulieu P, Rice AS, Di Marzo V. Melck D, et al. Adv Exp Med Biol. 2002;507:381-6. doi: 10.1007/978-1-4615-0193-0_59. Adv Exp Med Biol. 2002. PMID: 12664614 No abstract available.

4

Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin.

Bisogno T, Melck D, De Petrocellis L, Di Marzo V. Bisogno T, et al. Among authors: melck d. J Neurochem. 1999 May;72(5):2113-9. doi: 10.1046/j.1471-4159.1999.0722113.x. J Neurochem. 1999. PMID: 10217292 Free article.

5

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders.

De Petrocellis L, Melck D, Bisogno T, Di Marzo V. De Petrocellis L, et al. Among authors: melck d. Chem Phys Lipids. 2000 Nov;108(1-2):191-209. doi: 10.1016/s0009-3084(00)00196-1. Chem Phys Lipids. 2000. PMID: 11106791 Review.

6

N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.

Bisogno T, Melck D, Bobrov MYu, Gretskaya NM, Bezuglov VV, De Petrocellis L, Di Marzo V. Bisogno T, et al. Among authors: melck d. Biochem J. 2000 Nov 1;351 Pt 3(Pt 3):817-24. Biochem J. 2000. PMID: 11042139 Free PMC article.

7

Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.

Di Marzo V, Breivogel C, Bisogno T, Melck D, Patrick G, Tao Q, Szallasi A, Razdan RK, Martin BR. Di Marzo V, et al. Among authors: melck d. Eur J Pharmacol. 2000 Oct 20;406(3):363-74. doi: 10.1016/s0014-2999(00)00687-7. Eur J Pharmacol. 2000. PMID: 11040343

8

Cannabimimetic fatty acid derivatives in cancer and inflammation.

Di Marzo V, Melck D, De Petrocellis L, Bisogno T. Di Marzo V, et al. Among authors: melck d. Prostaglandins Other Lipid Mediat. 2000 Apr;61(1-2):43-61. doi: 10.1016/s0090-6980(00)00054-x. Prostaglandins Other Lipid Mediat. 2000. PMID: 10785541 Review.

9

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, Di Marzo V. Melck D, et al. Endocrinology. 2000 Jan;141(1):118-26. doi: 10.1210/endo.141.1.7239. Endocrinology. 2000. PMID: 10614630

10

Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.

Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Martin BR. Di Marzo V, et al. Among authors: melck d. Curr Med Chem. 1999 Aug;6(8):721-44. Curr Med Chem. 1999. PMID: 10469888 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results